- ►diabetesjournals.org S Fourlanos, C Perry, MS Stein, J Stankovich … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Subjects with LADA (n = 102, GAD antibody [GADA]+)
and type 2 diabetes (n = 111, GADA−) (aged 30–75 years) were interviewed
retrospectively. The clinical features documented were age of onset, acute ... Cited by 38 - Related articles - BL Direct - All 6 versions
A Maruyama, A Shimada, A KANATSUKA, A … - Ann. NY Acad. Sci, 2003 - interscience.wiley.com Abstract: In 1996, we designed a randomized multicenter study to assess the
effects of small doses of insulin on beta cell failure in slowly progressive
type 1 diabetes (the Tokyo Study). We report here the preliminary results ... Cited by 39 - Related articles - BL Direct - All 5 versions
- ►endojournals.org RDG Leslie, R Williams, P Pozzilli - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Context: The aim of this review was to explore the pathogenic and clinical
spectrum of type 1 diabetes, which includes a form of adult onset autoimmune
diabetes usually referred to as latent autoimmune diabetes in adults ... Cited by 55 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org S Brophy, K Yderstræde, D Mauricio, S Hunter … - Diabetes care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Patients were recruited in nine European centers,
and clinicians reported on criteria for initiating insulin. All patients were
tested for GAD antibodies (GADAs) in a central laboratory. We examined time ... Cited by 13 - Related articles - BL Direct - All 5 versions
M Desai, E Zeggini, VA Horton, KR Owen, AT … - Diabetologia, 2007 - Springer Page 1. SHORT COMMUNICATION An association analysis of the HLA gene region in latent
autoimmune diabetes in adults M. Desai & E. Zeggini & VA Horton & KR Owen & ... Cited by 15 - Related articles - BL Direct - All 14 versions
TME Davis, AD Wright, ZM Mehta, CA Cull, IM … - Diabetologia, 2005 - Springer Abstract Aims/hypothesis: We examined the prevalence of islet autoantibodies and
their relationship to glycaemic control over 10 years in patients diagnosed
clinically with new-onset type 2 diabetes. Methods: Patient clinical char- ... Cited by 41 - Related articles - All 3 versions
S Brophy, H Brunt, H Davies, S Mannan, R … - Cochrane database of systematic reviews (Online), 2007 - ncbi.nlm.nih.gov BACKGROUND: Latent autoimmune diabetes in Adults (LADA) is a slowly developing
type 1 diabetes which presents as non-insulin dependent diabetes and progresses
to insulin dependence. However, the best treatment strategy for LADA is ... Cited by 18 - Related articles
- ►diabetesjournals.org B Zinman, SE Kahn, SM Haffner, MC O'neill, MA … - Diabetes, 2004 - Am Diabetes Assoc A number of patients with type 2 diabetes are GAD antibody positive. A Diabetes
Outcome Progression Trial (ADOPT) is a randomized, double-blind clinical trial
in recently diagnosed drug-naïve patients with type 2 diabetes that allows ... Cited by 36 - Related articles - BL Direct - All 20 versions
M Desai, CA Cull, VA Horton, MR Christie, E … - Diabetologia, 2007 - Springer Abstract Aims/hypothesis Latent autoimmune diabetes in adults (LADA) is a slowly
progressive form of autoimmune diabetes, with autoantibodies to islet proteins
developing in older patients who have no immediate requirement for insulin ... Cited by 13 - Related articles - BL Direct - All 3 versions
R Buzzetti, S Di Pietro, A Giaccari, A Petrone, … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—Of 4,250 consecutive type 2 diabetic patients, 4.5% had either GADAs
and/or IA-2As. Patients with autoimmune diabetes showed a clinical phenotype
significantly different from that of type 2 diabetes, including higher ... Cited by 16 - Related articles - BL Direct - All 7 versions
